Experientia supplementum (2012) : Impact Factor & More
pISSN: 1664-431X
Share this on:
Key Metrics
CiteScore 
2
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Experientia supplementum (2012) Journal Specifications
Indexed in the following public directories
Scopus
| Overview | |
| Publisher | Springer Nature |
Planning to publish in Experientia supplementum (2012) ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Experientia supplementum (2012)
Role of ncRNAs in Neurological Disorders and Cardiovascular Diseases.
- 1 Jan 2026
- Experientia supplementum (2012)
Exploring the Role of Long Noncoding RNAs (lncRNAs) as Biomarkers in Cancers.
- 1 Jan 2026
- Experientia supplementum (2012)
The Transcriptional Role of Circular RNAs in Drug Resistance by Modulating the miRNA/mRNA Axis.
- 1 Jan 2026
- Experientia supplementum (2012)
Noncoding RNA in Clinical Trials: Diagnostic and Therapeutical Prospects.
- 1 Jan 2026
- Experientia supplementum (2012)
MicroRNAs as Biomarkers for the Diagnosis and Prognosis of Different Diseases and Cancer.
- 1 Jan 2026
- Experientia supplementum (2012)
MitomiRs as Key Players in Metabolic Reprogramming of Blood Cell Development.
- 1 Jan 2026
- Experientia supplementum (2012)
Role of ncRNAs in Neurological Disorders and Cardiovascular Diseases.
- 1 Jan 2026
- Experientia supplementum (2012)
Exploring the Role of Long Noncoding RNAs (lncRNAs) as Biomarkers in Cancers.
- 1 Jan 2026
- Experientia supplementum (2012)
The Transcriptional Role of Circular RNAs in Drug Resistance by Modulating the miRNA/mRNA Axis.
- 1 Jan 2026
- Experientia supplementum (2012)
Noncoding RNA in Clinical Trials: Diagnostic and Therapeutical Prospects.
- 1 Jan 2026
- Experientia supplementum (2012)
MicroRNAs as Biomarkers for the Diagnosis and Prognosis of Different Diseases and Cancer.
- 1 Jan 2026
- Experientia supplementum (2012)
MitomiRs as Key Players in Metabolic Reprogramming of Blood Cell Development.
- 1 Jan 2026
- Experientia supplementum (2012)
FAQs on Experientia supplementum (2012)
How many articles did Experientia supplementum (2012) publish last year? 
What is Citescore for Experientia supplementum (2012)?
Who is the publisher of Experientia supplementum (2012)?
